Life Sciences

Researchers have documented how transthyretin amyloid cardiomyopathy affects patients' everyday functioning and wellbeing. The findings could help pharmaceutical companies and health systems better measure treatment success and design patient support programs for this serious but treatable condition.EN

A mouse study finds that increasing GDNF, a protein long considered protective for dopamine neurons, provides no benefit in Parkinson's disease models. The finding challenges a leading therapeutic strategy and suggests developers need to rethink how to deliver or deploy the protein to be effective.EN

A 12-year study found that olfactory dysfunction is a reliable early marker of dementia risk, potentially enabling earlier interventions. For healthcare systems and pharmaceutical companies, this finding offers a simple, non-invasive screening tool that could identify at-risk populations before cognitive decline becomes severe—opening new opportunities in preventive care and drug development.EN

Researchers have developed a faster, cheaper way to sequence genes from extremely small numbers of cells—even just lysed cell material. The technique could accelerate drug development, diagnostics, and basic research by making it practical to study individual cells or scarce tissue samples that were previously too difficult to analyze.EN

Researchers found that acyl ghrelin, a naturally occurring hormone, restores heart function in heart failure patients by improving how effectively heart muscle contracts—using an entirely different mechanism than existing drugs. The discovery could lead to new treatments for the millions worldwide living with heart failure, a condition that costs healthcare systems billions annually.EN

A new study finds that melanoma patients who take metformin for diabetes show improved survival rates compared to those who don't use the drug. The finding could reshape treatment strategies for the roughly 20% of melanoma patients with diabetes, potentially offering a low-cost intervention that extends life.EN

A new study reveals that healthcare workers in North-East Nigeria are unprepared to implement comprehensive cholera prevention strategies, jeopardizing outbreak response in a high-risk region. The findings point to critical gaps in training and knowledge that policy makers must address to prevent disease spread and protect public health infrastructure.EN

Researchers have pinpointed three previously unknown genetic variants that increase colorectal cancer risk by analyzing patterns across multiple cancer types. The discovery could improve genetic screening and help doctors identify high-risk patients earlier, potentially reducing treatment costs and improving outcomes for a disease that affects over 1 million people annually worldwide.EN

Researchers discovered that early HPV infection rewires cell genetics in ways that disappear as precancerous lesions advance. The finding suggests doctors may be missing a critical window to detect and treat cervical cancer before it becomes truly dangerous—potentially reshaping screening and prevention strategies.EN

Researchers identified a cellular mechanism in Langerhans cell histiocytosis—a rare blood disorder—where abnormal myeloid cells activate natural killer immune cells through changes in how they release proteins. The finding could guide development of targeted treatments for a disease that currently lacks effective therapies and primarily affects children.EN

Researchers have identified tiny RNA molecules in blood serum that could serve as non-invasive markers for acute myeloid leukemia (AML). If validated, the finding could enable earlier detection and monitoring without bone marrow biopsies, potentially reducing costs and improving patient outcomes in a disease where timing is critical.EN

Scientists have identified galectin-3 as a driver of neural dysfunction in Alzheimer's disease, specifically how it disrupts the brain's electrical synchronization critical for memory and cognition. The finding opens a new therapeutic avenue for a protein that could be drugged, potentially slowing cognitive decline before irreversible brain damage occurs.EN

Researchers identified how brain network communication changes in Alzheimer's disease correlate with amyloid and tau protein buildup—the pathological hallmarks of the condition. The finding could help clinicians better predict disease progression and assess which patients will benefit most from emerging anti-amyloid therapies.EN

Researchers have translated and tested a Swedish version of a visual vertigo scale used to assess dizziness severity in patients. The validated tool could improve diagnosis and treatment monitoring for balance disorders in Swedish clinical settings, where standardized measurement tools are critical for consistent patient care.EN

Researchers characterized a cohort of Iranian patients with DCLRE1C gene defects, a rare condition that cripples the immune system. The findings could help clinicians identify and manage the disease earlier, potentially improving outcomes for affected families and informing genetic screening policies.EN

The International Society for Cell & Gene Therapy convened experts to assess therapeutic potential of extracellular vesicles—tiny cell-derived particles being developed as drug delivery vehicles and treatments. The findings could reshape how companies approach next-generation cell therapies and influence regulatory decisions on what counts as a viable treatment modality.EN

Researchers have identified that mutations in the ADAMTSL2 gene cause Al-Gazali skeletal dysplasia, a severe bone disorder that represents the most extreme form of related genetic conditions. The finding could enable earlier diagnosis and inform treatment strategies for families carrying this mutation, with implications for genetic testing and rare disease management.EN

Scientists combined genetic and protein analysis to track how breast cancers evolve within individual patients, revealing patterns that could improve treatment decisions. The findings suggest doctors may one day predict which tumors will become aggressive, potentially shifting how oncologists personalize therapy and monitor patient outcomes.EN

Researchers have discovered a naturally occurring dipeptide found in HIV patients who can control the virus without treatment, which works through two distinct biological mechanisms. The finding could guide development of new therapies for a disease affecting 39 million people globally and represents a shift toward understanding why some patients' immune systems outperform standard drugs.EN

Researchers have demonstrated a new way to control gene expression by editing the 3' UTR—a regulatory region that acts like a dimmer switch for genes—directly in living animals. This approach could enable more precise treatments for genetic diseases and offer pharmaceutical companies a novel way to modulate disease-driving genes without permanently altering DNA.EN

Researchers tracked how neural damage indicators fluctuate in brain injury patients over time, using cerebrospinal fluid samples. The findings could help clinicians detect severity faster and monitor recovery, potentially improving treatment decisions and outcomes in a field where minutes matter.EN

A new study finds that one dose of the antidepressant escitalopram works nearly as well as a professional therapy session at helping people regulate fear and disgust responses. The finding could reshape how psychiatrists approach acute anxiety and phobia treatment, potentially offering faster relief while reducing pressure on mental health services.EN

Researchers have identified a glycan signature in blood serum that predicts progression to Alzheimer's disease, especially when combined with genetic risk factors. The finding could enable earlier diagnosis and intervention, potentially transforming treatment windows for a disease affecting millions globally.EN

A large Swedish registry analysis found that transcranial magnetic stimulation—a non-invasive brain treatment—effectively treats depression in patients who haven't responded to medication. The finding could reshape how health systems manage treatment-resistant depression, reducing reliance on pharmaceutical interventions and potentially lowering long-term care costs.EN

Researchers have developed a method to identify which versions of genes are expressed in specific locations within tissue sections, a capability that could accelerate drug development and disease diagnosis. The advance enables scientists to see how genetic variation affects different cell populations in the same tissue—information pharmaceutical companies need to predict drug responses and understand disease mechanisms.EN